Table 2

Baseline Clinical and Procedure Characteristics of the PCI Cohort

Radial
(n = 345)
Femoral
(n = 346)
p Value
Age, yrs65.1 (56.5, 73.7)63.9 (56.5, 72.9)0.32
BMI, kg/m230.1 (25.9, 34.5)30.5 (26.9, 35.4)0.14
Current or recent smoking106 (30.7)102 (29.5)0.72
Hypertension296 (85.8)294 (85.0)0.76
Previous MI82 (23.8)96 (27.7)0.23
Previous CABG25 (7.2)34 (9.9)0.22
Hemodialysis2 (0.6)2 (0.6)>0.99
Peripheral arterial disease23 (6.7)29 (8.4)0.39
Diabetes mellitus144 (41.7)154 (44.5)0.46
Clinical presentation0.50
 Non-ACS98 (28.4)94 (27.2)
 NSTEACS244 (70.7)251 (72.5)
 STEMI3 (0.9)1 (0.3)
PCI status0.49
 Elective133 (46.5)123 (43.6)
 Urgent149 (52.1)157 (55.7)
 Emergent4 (1.4)2 (0.7)
Bivalirudin166 (59.1)181 (65.8)0.10
Glycoprotein IIb/IIIa inhibitor32 (11.4)32 (11.6)0.93
Vascular closure device15 (5.1)194 (65.5)< 0.001

Values shown are number (%) or median (25th, 75th percentiles).

PCI = percutaneous coronary intervention; other abbreviations as in Table 1.

  • Excludes patients who underwent fractional flow reserve, intravascular ultrasound, or optical coherence tomography without coronary angioplasty or stenting.

  • Patients who had any femoral arterial access.